StockWatch
·
Medical/Nursing Services
Quarterly ResultAug 10, 2026, 09:46 AM

AirSculpt Q2 Revenue $42.9M, Net Loss $(1.1M); Debt Reduced

AI Summary

AirSculpt Technologies reported a Q2 2026 revenue of $42.9 million, a decrease from $44.0 million in Q2 2025, and an increased net loss of $(1.1) million compared to $(0.6) million in the prior year. For the six months ended June 30, 2026, the company's net loss was $(3.5) million. Despite the losses, AirSculpt significantly improved its balance sheet, increasing cash and cash equivalents to $18.8 million and reducing long-term debt to $33.1 million. The company also amended its credit agreement, extending debt maturity and outlining further debt repayment requirements from equity proceeds.

Key Highlights

  • Q2 2026 revenue was $42.9 million, down from $44.0 million in Q2 2025.
  • Net loss for Q2 2026 increased to $(1.1) million from $(0.6) million in Q2 2025.
  • Basic loss per share for Q2 2026 was $(0.02), compared to $(0.01) in Q2 2025.
  • Cash and cash equivalents rose to $18.8 million as of June 30, 2026, from $8.4 million.
  • Long-term debt, net, decreased to $33.1 million from $50.6 million at Dec 31, 2025.
  • Credit agreement amended, extending debt maturity to November 15, 2027.
  • Required $2.5 million payment upon signing debt amendment, another $2.5 million by Sept 30, 2026.
  • 50% of future equity proceeds to prepay term loans.